[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=AKRO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=AKRO &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

6.07

Margin Of Safety %

Put/Call OI Ratio

0.84

EPS Next Q Diff

0.01

EPS Last/This Y

0.01

EPS This/Next Y

-0.38

Price

54.34

Target Price

56.29

Analyst Recom

2.75

Performance Q

14.18

Relative Volume

0.53

Beta

-0.39

Ticker: AKRO

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	AKRO	53.91	0.87	1.00	30541
2025-10-21	AKRO	53.82	0.86	0.15	30473
2025-10-22	AKRO	53.61	0.86	46.75	30481
2025-10-23	AKRO	53.71	0.88	0.20	30683
2025-10-24	AKRO	53.79	0.87	0.31	30763
2025-10-27	AKRO	53.83	0.88	0.03	30716
2025-10-28	AKRO	54.01	0.87	2.51	30914
2025-10-29	AKRO	54.01	0.87	12.10	31114
2025-10-30	AKRO	54.26	0.90	0.00	31100
2025-10-31	AKRO	54.2	0.89	3.49	31117
2025-11-03	AKRO	54.1	0.91	3.98	31434
2025-11-04	AKRO	54.03	0.92	0.01	31650
2025-11-05	AKRO	54.04	0.89	0.05	32239
2025-11-06	AKRO	53.95	0.85	9.00	33145
2025-11-07	AKRO	54.03	0.85	0.17	33182
2025-11-10	AKRO	54.15	0.85	0.56	33315
2025-11-11	AKRO	54.24	0.85	0.05	33319
2025-11-12	AKRO	54.29	0.85	0.05	33319
2025-11-13	AKRO	54.2	0.84	0.90	33360
2025-11-14	AKRO	54.26	0.84	0.14	33320
2025-11-17	AKRO	54.34	0.84	3.75	33361
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	AKRO	53.91	11.1	-	-3.73
2025-10-21	AKRO	53.82	11.1	-	-3.73
2025-10-22	AKRO	53.61	11.1	-	-3.73
2025-10-23	AKRO	53.71	11.1	-	-3.73
2025-10-24	AKRO	53.79	11.1	-	-3.73
2025-10-27	AKRO	53.85	11.1	-	-3.73
2025-10-28	AKRO	54.00	11.1	-	-3.73
2025-10-29	AKRO	54.01	11.1	-	-3.73
2025-10-30	AKRO	54.26	11.1	-	-3.73
2025-10-31	AKRO	54.21	11.1	-	-3.73
2025-11-03	AKRO	54.11	11.1	-	-3.73
2025-11-04	AKRO	54.05	11.1	-	-3.73
2025-11-05	AKRO	54.04	11.1	-	-3.73
2025-11-06	AKRO	53.92	11.1	-	-3.73
2025-11-07	AKRO	54.04	11.1	-	-3.73
2025-11-10	AKRO	54.14	11.1	-	-3.73
2025-11-11	AKRO	54.25	2.2	-	-3.73
2025-11-12	AKRO	54.30	10.1	-	-3.74
2025-11-13	AKRO	54.22	10.1	-	-3.74
2025-11-14	AKRO	54.25	10.1	-	-3.74
2025-11-17	AKRO	54.34	10.1	-	-3.74
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	AKRO	-4.21	10.22	14.08
2025-10-21	AKRO	-4.21	10.22	14.08
2025-10-22	AKRO	-4.21	10.22	14.08
2025-10-23	AKRO	-4.21	10.22	14.08
2025-10-24	AKRO	-4.21	10.22	14.08
2025-10-27	AKRO	-4.21	10.11	8.22
2025-10-28	AKRO	-4.21	10.11	8.22
2025-10-29	AKRO	-4.12	10.11	8.16
2025-10-30	AKRO	-4.12	10.11	8.16
2025-10-31	AKRO	-4.12	10.11	8.16
2025-11-03	AKRO	-4.12	11.86	8.16
2025-11-04	AKRO	-4.12	11.86	8.16
2025-11-05	AKRO	-4.12	11.86	8.16
2025-11-06	AKRO	-4.12	11.86	8.16
2025-11-07	AKRO	-4.12	11.86	8.16
2025-11-10	AKRO	-3.93	11.34	8.16
2025-11-11	AKRO	-3.92	11.34	8.16
2025-11-12	AKRO	-3.85	11.34	6.07
2025-11-13	AKRO	-3.85	11.34	6.07
2025-11-14	AKRO	-3.56	11.34	6.07
2025-11-17	AKRO	-3.56	18.81	6.07
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=AKRO 589 360 ]

Last Quarter Act. EPS

-0.99

Avg. EPS Est. Current Quarter

-0.89

Avg. EPS Est. Next Quarter

-0.98

Insider Transactions

-3.56

Institutional Transactions

18.81

Beta

-0.39

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-80

Target Price

56.29

P/E

Forward P/E

PEG

P/S

P/B

4.55

P/Free Cash Flow

EPS

-3.75

Average EPS Est. Cur. Y

-3.74

EPS Next Y. (Est.)

-4.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.53

Return on Equity vs Sector %

-57.5

Return on Equity vs Industry %

-42.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=AKRO 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=AKRO 589 450 ]

Akero Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 74

Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

stock quote shares AKRO – Akero Therapeutics Inc Stock Price stock today

news today AKRO – Akero Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch AKRO – Akero Therapeutics Inc yahoo finance google finance

stock history AKRO – Akero Therapeutics Inc invest stock market

stock prices AKRO premarket after hours

ticker AKRO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AKRO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y